Table 5.
Correlation of tumour biomarker levels, CV morbidity and mortality, and ACM.
| MV correction + CRP | ||
|---|---|---|
| CV | HR (95% CI) | P |
| CA 15-3 | 1.10 (0.87–1.40) | 0.398 |
| CEA 1.27 | (1.07–1.52) | 0.006 |
| CYFRA 21-1 | 1.27 (1.03–1.56) | 0.021 |
| ACM | HR (95% CI) | P |
| CA 125 | 1.26 (1.01–1.56) | 0.037 |
| CA 15-3 | 1.58 (1.16–2.15) | 0.003 |
| CEA | 1.60 (1.30–1.98) | 0.000 |
| CYFRA 21-1 | 1.24 (0.98–1.58) | 0.065 |
MV correction is adjusted for age, gender, BMI, smoking habits, TCL, glucose levels, SBP, prevalent CVD and CRP.
CV, cardiovascular; HR, hazard ratio; MV, multivariable; CVD, cardiovascular disease; ACM, all-cause mortality; BMI, body mass index; TCL, total cholesterol; SBP, systolic blood pressure; CA, cancer antigen; CEA, carcinoembryonic antigen; CYFRA, cytokeratin fragment.